[
1. Thway K, Noujaim J, Jones RL, Fisher C. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies. Ann Diagn Pathol. 2016 Dec; 25:64-71. doi: 10.1016/j.anndiagpath.2016.09.013.10.1016/j.anndiagpath.2016.09.01327806849
]Search in Google Scholar
[
2. Reha J, Katz SC. Dermatofibrosarcoma Protuberans. Surg Clin North Am. 2016 Oct; 96(5):1031-46. doi: 10.1016/j.suc.2016.05.006.10.1016/j.suc.2016.05.00627542641
]Search in Google Scholar
[
3. Llombart B, Serra-Guillén C, Monteagudo C, López Guerrero JA, Sanmartín O. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013 Feb; 30(1):13-28. doi: 10.1053/j.semdp.2012.01.002.10.1053/j.semdp.2012.01.00223327727
]Search in Google Scholar
[
4. Orlandi A, Bianchi L, Spagnoli LG. Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features. J Cutan Pathol. 1998 Aug; 25(7):386-93. doi: 10.1111/j.1600-0560.1998.tb01763.x.10.1111/j.1600-0560.1998.tb01763.x9765025
]Search in Google Scholar
[
5. Almeida FT, Carvalho SD, Pereira T, Brito C. When a bruise gets important: Bednar tumour. BMJ Case Rep. 2019 Feb 11; 12(2):e228446. doi: 10.1136/bcr-2018-228446.10.1136/bcr-2018-228446638194430755432
]Search in Google Scholar
[
6. Ferlosio A, Di Prete M, Rossi P, Campione E, Orlandi A. Bednar Tumour Occurring after Malignant Melanoma Excision. Case Rep Pathol. 2018 Oct 1; 2018:7694272. doi: 10.1155/2018/7694272.10.1155/2018/7694272618885730364040
]Search in Google Scholar
[
7. Añón-Requena MJ, Pico-Valimaña M, Muñoz-Arias G. Bednar Tumor (Pigmented Dermatofibrosarcoma Protuberans). Actas Dermosifiliogr. 2016 Sep; 107(7):618-20. doi: 10.1016/j.ad.2015.10.017.10.1016/j.ad.2015.10.01726945477
]Search in Google Scholar
[
8. Kaul R, Kaur N, Dogra SS, Chander B. Variant of dermatofibrosarcoma protuberans: bednar tumor. Indian J Dermatol. 2015 Jan-Feb; 60(1):107. doi: 10.4103/0019-5154.147885.10.4103/0019-5154.147885431804725657441
]Search in Google Scholar
[
9. Bednar B. Storiform neurofibromas of the skin, pigmented and nonpigmented. Cancer. 1957 Mar-Apr; 10(2):368-76. doi: 10.1002/1097-0142(195703/04)10:2<368:aid-cncr2820100218>3.0.co;2-3.
]Search in Google Scholar
[
10. Fletcher CD, Theaker JM, Flanagan A, Krausz T. Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study. Histopathology. 1988 Dec; 13(6):631-43. doi: 10.1111/j.1365-2559.1988.tb02094.x.10.1111/j.1365-2559.1988.tb02094.x2466752
]Search in Google Scholar
[
11. Kreicher KL, Kurlander DE, Gittleman HR, Barnholtz-Sloan JS, Bordeaux JS. Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States. Dermatol Surg. 2016 Jan; 42 Suppl 1:S24-31. doi: 10.1097/DSS.0000000000000300.10.1097/DSS.000000000000030026730971
]Search in Google Scholar
[
12. Amonkar GP, Rupani A, Shah A, Deshpande R. Bednar Tumor: An Uncommon Entity. Dermatopathology (Basel). 2016 Apr 20; 3(2):36-8. doi: 10.1159/000445714.10.1159/000445714496553827504443
]Search in Google Scholar
[
13. Jing C, Zhang H, Zhang X, Yu S. Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution. Dermatol Surg. 2021 Feb 1; 47(2):e26-e30. doi: 10.1097/DSS.0000000000002578.10.1097/DSS.000000000000257832769521
]Search in Google Scholar
[
14. Allen A, Ahn C, Sangüeza OP. Dermatofibrosarcoma Protuberans. Dermatol Clin. 2019 Oct; 37(4):483-488. doi: 10.1016/j.det.2019.05.006.10.1016/j.det.2019.05.00631466588
]Search in Google Scholar
[
15. Hayakawa K, Matsumoto S, Ae K, Tanizawa T, Gokita T, Funauchi Y, Motoi N. Risk factors for distant metastasis of dermatofibrosarcoma protuberans. J Orthop Traumatol. 2016 Sep; 17(3):261-6. doi: 10.1007/s10195-016-0415-x.10.1007/s10195-016-0415-x499938027289468
]Search in Google Scholar
[
16. Stacchiotti S, Pedeutour F, Negri T, Conca E, Marrari A, Palassini E, Collini P, Keslair F, Morosi C, Gronchi A, Pilotti S, Casali PG. Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib. Int J Cancer. 2011 Oct 1; 129(7):1761-72. doi: 10.1002/ijc.25826. Erratum in: Int J Cancer. 2017 May 15; 140(10):E13.10.1002/ijc.2582621128251
]Search in Google Scholar
[
17. Lopez LV, Yatsenko SA, Burgess M, Schoedel K, Rao UNM. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: our experience, molecular evaluation of selected cases, and short literature review. Int J Dermatol. 2019 Nov; 58(11):1246-1252. doi: 10.1111/ijd.14462.10.1111/ijd.1446230968395
]Search in Google Scholar
[
18. Brooks J, Ramsey ML. Dermatofibrosarcoma Protuberans. 2021 Feb 15. In: StatPearls, 2021 Jan, Treasure Island (FL), StatPearls Publishing.
]Search in Google Scholar
[
19. González A, Etchichury D, Rivero JM, Adamo L. Treatment of dermatofibrosarcoma of the head and neck with Mohs surgery with paraffin sections. J Plast Reconstr Aesthet Surg. 2021 May; 74(5):1061-1070. doi: 10.1016/j.bjps.2020.10.062.10.1016/j.bjps.2020.10.06233317985
]Search in Google Scholar
